Clinical trial / 2013
Daily cranberry beverage consumption enhanced ex vivo γδ-T cell proliferation and reduced cold and flu symptoms in a randomized trial.
In a randomized, double-blind, placebo-controlled parallel trial, subjects drank 450 ml of a low-calorie cranberry beverage (n = 22) or a placebo beverage (n = 23) daily for 10 weeks. After 10 weeks, the proliferation index of cultured γδ-T cells was almost five times higher in the cranberry group (p < 0.001). Although the incidence of illness was not reduced, significantly fewer symptoms of illness were reported in the cranberry beverage group (p = 0.031).
- Study type
- Randomized, double-blind, placebo-controlled, parallel trial
- Who was studied
- 45 subjects (22 cranberry group, 23 placebo group)
- What was measured
- γδ-T cell proliferation and cold and influenza symptoms
THE PAPER
Consumption of cranberry polyphenols enhances human γδ-T cell proliferation and reduces the number of symptoms associated with colds and influenza: a randomized, placebo-controlled intervention study.
Nantz MP, Rowe CA, Muller C, Creasy R, Colee J, Khoo C, Percival SS. Nutr J, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.